Grail (GRAL) Rated Buy by Guggenheim on Galleri Potential
Grail Inc. (NASDAQ:GRAL) ranks among the recent spin-off companies that hedge funds are piling into.
Grail Inc. (GRAL)
Market is closed
Sector: Services-Medical Laboratories
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Bayforest Capital Theodoros Tsagaris | 7,262 | $375,300 | 0.42% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $12.92 | 16,200 | $209,304.00 | 3,644,855 | 2024-10-09 | Filing | |
| $12.71 | 35,000 | $444,850.00 | 3,558,655 | 2024-10-03 | Filing | |
| $13.37 | 20,000 | $267,400.00 | 3,523,655 | 2024-10-02 | Filing | |
| $13.52 | 7,629 | $103,144.08 | 3,503,655 | 2024-10-01 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $49.92 | 45,806 | $2,286,525.59 | 260,669 | 2026-04-08 | Filing | |
| $49.92 | 123,502 | $6,164,923.44 | 518,582 | 2026-04-08 | Filing | |
| $49.92 | 61,665 | $3,078,168.80 | 371,216 | 2026-04-08 | Filing | |
| $46.74 | 85 | $3,972.90 | 306,475 | 2026-03-09 | Filing | |
| $47.93 | 2,407 | $115,367.51 | 306,560 | 2026-03-09 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 161,524 | $8,347,560 | 0.12% | |
| 2. | 31,795 | $1,748,407 | 0% | |
| 3. | 19,803 | $1,023,420 | 0.02% | |
| 4. | 17,437 | $901,144 | 0.01% | |
| 5. | 16,127 | $833,443 | 0.24% |
News See All
10 Recent Spin-off Companies That Hedge Funds Are Piling Into
Spin-offs enable businesses to reduce operational burdens and focus on their most strategic options.
Here's What Analysts Are Saying About Grail Inc. (GRAL)
Grail Inc. (NASDAQ:GRAL) is one of the best small-cap stocks with huge growth potential. On February 20, Baird cut the price target on Grail Inc.
GRAIL, Inc. (NASDAQ:GRAL) Q4 2025 Earnings Call Transcript
Operator: Good day, ladies and gentlemen, and welcome to the GRAIL Fourth Quarter 2025 Earnings Call. [Operator Instructions] Please be advised that this conference call is being recorded.
10 Small-Cap Stocks With Huge Growth Potential
On February 19, Ben Snider, Goldman Sachs chief U.S. equity strategist, appeared on CNBC’s ‘Money Movers’ to talk about his playbook for equities, among other things.
Grail Inc (GRAL) Climbs 380% on Strong Optimism for Cancer Detection Kit
Called Galleri, the tool is a single blood test designed to screen more than 50 types of cancer.
Morgan Stanley Eyes Emerging Growth for Grail (GRAL) as Sector Valuations Reach Equilibrium
Grail Inc. (NASDAQ:GRAL) is one of the best emerging technology stocks to invest in.
12 Best Emerging Technology Stocks to Invest In
On December 24, Kevin Simpson of Capital Wealth Planning joined 'Closing Bell' on CNBC to talk about AI tailwinds and the diverging tech picture.
GRAIL, Inc. (NASDAQ:GRAL) Q3 2025 Earnings Call Transcript
Operator: Good day, ladies and gentlemen. And welcome to the GRAIL Third Quarter 2025 Earnings Call. At this time, all participants are in listen-only mode.
13 Stocks Jim Cramer Put Under the Spotlight Recently
“On a day like today, you get a sense that many stocks have indeed gotten ahead of themselves after a very strong rally.